Partnering
From R&D to diagnostics, Okomera supports the entire oncology value chain to deliver better therapies to patients.
Clinicians
The right treatment upfront.
Every patient is different and their treatment should be too. With Okomera, clinicians can use routine tumor samples to rapidly observe how a patient’s tumor responds to different therapeutic options.
Designed to align with real-world clinical timelines, Okomera’s approach supports faster, more personalized treatment decisions based on functional biological response.
Pharma
Capture real drug response to accelerate development.
Okomera helps pharma teams generate clinically relevant efficacy signals from patient-derived tumor samples. With fast turnaround times and low sample requirements, the platform supports smarter decisions across discovery, translational research and clinical development.
From prioritizing pipelines to stratifying patients and designing better trials, Okomera helps reduce uncertainty by grounding decisions in real tumor response.
